MAPK8IP3
C-Jun-amino-terminal kinase-interacting protein 3
Also known as: JIP3, JIP3_HUMAN, JSAP1, KIAA1066, syd
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UPT6
- Gene
- MAPK8IP3
- Ensembl
- ENSG00000138834
- Chromosome
- 16
- Canonical length
- 1336 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles
OverviewNCBI Gene
The protein encoded by this gene shares similarity with the product of Drosophila syd gene, required for the functional interaction of kinesin I with axonal cargo. Studies of the similar gene in mouse suggested that this protein may interact with, and regulate the activity of numerous protein kinases of the JNK signaling pathway, and thus function as a scaffold protein in neuronal cells. The C. elegans counterpart of this gene is found to regulate synaptic vesicle transport possibly by integrating JNK signaling and kinesin-1 transport. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
1336 residues, UniProt reviewed canonical sequence.
>Q9UPT6|MAPK8IP3
1 MMEIQMDEGG GVVVYQDDYC SGSVMSERVS GLAGSIYREF ERLIHCYDEE VVKELMPLVV
61 NVLENLDSVL SENQEHEVEL ELLREDNEQL LTQYEREKAL RRQAEEKFIE FEDALEQEKK
121 ELQIQVEHYE FQTRQLELKA KNYADQISRL EERESEMKKE YNALHQRHTE MIQTYVEHIE
181 RSKMQQVGGN SQTESSLPGR RKERPTSLNV FPLADGTVRA QIGGKLVPAG DHWHLSDLGQ
241 LQSSSSYQCP QDEMSESGQS SAAATPSTTG TKSNTPTSSV PSAAVTPLNE SLQPLGDYGV
301 GSKNSKRARE KRDSRNMEVQ VTQEMRNVSI GMGSSDEWSD VQDIIDSTPE LDMCPETRLD
361 RTGSSPTQGI VNKAFGINTD SLYHELSTAG SEVIGDVDEG ADLLGEFSVR DDFFGMGKEV
421 GNLLLENSQL LETKNALNVV KNDLIAKVDQ LSGEQEVLRG ELEAAKQAKV KLENRIKELE
481 EELKRVKSEA IIARREPKEE AEDVSSYLCT ESDKIPMAQR RRFTRVEMAR VLMERNQYKE
541 RLMELQEAVR WTEMIRASRE HPSVQEKKKS TIWQFFSRLF SSSSSPPPAK RPYPSVNIHY
601 KSPTTAGFSQ RRNHAMCPIS AGSRPLEFFP DDDCTSSARR EQKREQYRQV REHVRNDDGR
661 LQACGWSLPA KYKQLSPNGG QEDTRMKNVP VPVYCRPLVE KDPTMKLWCA AGVNLSGWRP
721 NEDDAGNGVK PAPGRDPLTC DREGDGEPKS AHTSPEKKKA KELPEMDATS SRVWILTSTL
781 TTSKVVIIDA NQPGTVVDQF TVCNAHVLCI SSIPAASDSD YPPGEMFLDS DVNPEDPGAD
841 GVLAGITLVG CATRCNVPRS NCSSRGDTPV LDKGQGEVAT IANGKVNPSQ STEEATEATE
901 VPDPGPSEPE TATLRPGPLT EHVFTDPAPT PSSGPQPGSE NGPEPDSSST RPEPEPSGDP
961 TGAGSSAAPT MWLGAQNGWL YVHSAVANWK KCLHSIKLKD SVLSLVHVKG RVLVALADGT
1021 LAIFHRGEDG QWDLSNYHLM DLGHPHHSIR CMAVVYDRVW CGYKNKVHVI QPKTMQIEKS
1081 FDAHPRRESQ VRQLAWIGDG VWVSIRLDST LRLYHAHTHQ HLQDVDIEPY VSKMLGTGKL
1141 GFSFVRITAL LVAGSRLWVG TGNGVVISIP LTETVVLHRG QLLGLRANKT SPTSGEGARP
1201 GGIIHVYGDD SSDRAASSFI PYCSMAQAQL CFHGHRDAVK FFVSVPGNVL ATLNGSVLDS
1261 PAEGPGPAAP ASEVEGQKLR NVLVLSGGEG YIDFRIGDGE DDETEEGAGD MSQVKPVLSK
1321 AERSHIIVWQ VSYTPELocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAPK8IP3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 184 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 184 nTPM
- cerebral cortex: 107 nTPM
- pituitary gland: 75 nTPM
- hippocampal formation: 70 nTPM
- hypothalamus: 62 nTPM
- basal ganglia: 61 nTPM
Single-cell type
- retinal ganglion cells: 240 nCPM
- retinal horizontal cells: 228 nCPM
- somatotrophs: 175 nCPM
- endometrial glandular cells: 163 nCPM
- lactotrophs: 150 nCPM
- retinal amacrine cells: 139 nCPM
Immune cell
- eosinophil: 3 nTPM
- memory B-cell: 1.7 nTPM
- plasmacytoid DC: 1.7 nTPM
- naive B-cell: 1.6 nTPM
- classical monocyte: 0.6 nTPM
- basophil: 0.5 nTPM
Brain region
- cerebral cortex: 237 nTPM
- white matter: 191 nTPM
- hippocampal formation: 185 nTPM
- medulla oblongata: 184 nTPM
- pons: 180 nTPM
- basal ganglia: 161 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about MAPK8IP3.
Disease | AllUniProt
Conditions MAPK8IP3 is implicated in, by any mechanism.
- Neurodevelopmental disorder with or without variable brain abnormalities (NEDBA) MIM:618443
Disease | GeneticClinVar
20 pathogenic / likely-pathogenic of 594 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Neurodevelopmental disorder with or without variable brain abnormalities
- NEDBA
- Inborn genetic diseases
- MAPK8IP3-related disorder
- Neurodevelopmental disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.15
- gnomAD pLI
- 1
- gnomAD missense Z
- 2.88
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- anterograde axonal protein transport
- axon development
- axon regeneration
- negative regulation of apoptotic process
- positive regulation of JNK cascade
- protein stabilization
- regulation of JNK cascade
- vesicle-mediated transport
Molecular functions
- JUN kinase binding
- kinesin binding
- MAP-kinase scaffold activity
- signaling receptor complex adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAPK8IP3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAPK8IP3 as an antibody target. Whether an autoantibody or antibody against MAPK8IP3 could matter depends on whether native MAPK8IP3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAPK8IP3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAPK8IP3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...